Boyds announced as Proud Patron of CAT FM
The Cat, local radio station for Crewe and Nantwich, has announced a partnership with Boyds, global drug development consultancy.
CTD to CTR: Clinical Trials Regulation: ongoing trials beyond 31 January 2025
If you are running any clinical trials, approved under the Clinical Trials Directive, that will continue to run after 31 January 2025, you will need to comply with the Clinical Trials Regulation (Regulation (EU) No 536/2014)
Boyds announces trio of promotions
Our leading Regulatory Affairs Group has promoted Dr Sabine Rühle to Director of Regulatory Affairs and Navila Rehman to Senior Manager, Quality Assurance and Regulatory Operations.
Dr Karen Mullen awarded Fellowship of the Royal College of Physicians
Boyds’ Chief Medical Officer Dr Karen Mullen has been awarded Fellowship of the Royal College of Physicians. The prestigious award recognises Karen’s standout contribution to medicine. The Royal College of Physicians (RCP) is an independent patient centered and clinically led organisation that drives improvement in the diagnosis of disease, the care of individual patients and […]
Boyds Regulatory Team contribute to May issue of Regulatory Rapporteur
In the May issue of the TOPRA journal, Regulatory Rapporteur, members of Boyds award-winning regulatory team made significant contributions to the respected, international peer-reviewed journal.
New senior hire for medical writing team at Boyds with appointment of Naomi Clout
We are delighted to welcome Naomi Clout to the team as Senior Regulatory and Medical Writer, after working with the company on a consultancy basis for a number of years.
Carving out a career as a female pharma leader: interview with Dr Karen Mullen
Boyds’ Chief Medical Officer Dr Karen Mullen was recently interviewed by Pf Media about her career journey as a female pharma leader.
Professor Alan Boyd explains the science behind gene therapy in Open Access Government article
An article authored by President and CEO, Professor Alan Boyd, was recently featured in Open Access Government.
Experts at Boyds talk funding for cell and gene therapy development
Dr Nick Meyers, Vice President of Product Development, and Dr Neil Fish, Vice President of Business Development, recently discussed the availability of funding for cell and gene therapy product development with Cell and Gene Therapy Insights.
Spring Budget: R&D tax relief rate announcement
In the Spring Budget, the Chancellor has announced an enhanced R&D tax relief rate for ‘R&D intensive SMEs.’ Professor Alan Boyd, CEO and president of Boyds, responds to the news.
